Mankind Pharma Limited (NSE:MANKIND)
India
· Delayed Price · Currency is INR 2,325.20
-33.10 (-1.40%)
Jun 19, 2025, 3:30 PM IST
Mankind Pharma Revenue
In the fiscal year ending March 31, 2025, Mankind Pharma had annual revenue of 122.07B INR with 18.12% growth. Mankind Pharma had revenue of 30.79B in the quarter ending March 31, 2025, with 26.15% growth.
Revenue
122.07B
Revenue Growth
+18.12%
P/S Ratio
7.97
Revenue / Employee
6.25M
Employees
19,540
Market Cap
973.34B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
| Fortis Healthcare | 77.83B |